RBM15 and acute myeloid leukemia: As shown in Figure 4a-k, ZCH13H (P = 0.043), YTHDF1 (P = 0.023), RBM15 (P = 0.014), METLL3 (P = 0.003) and HNRNPC (P = 0.005) were remarkably related to worse prognoses in AML patients.